A Fresh Look at Vaccines Returning to First Principles Clarus Biologics, Inc. Clarus Biologics is developing a two component vaccine strategy. Component One: A virus-like particle (VLP) which sends a strong non-specific activation signal to the immune system, just...
Recent Comments